Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis - Wikidata - wikimedia - TriplyDB

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

http://www.wikidata.org/entity/Q28082878

about

Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.Tolerogenic Vaccination with MOG/VitD Overcomes Aggravating Effect of C. albicans in Experimental Encephalomyelitis.Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease.Trichinella spiralis Excretory-Secretory Products Induce Tolerogenic Properties in Human Dendritic Cells via Toll-Like Receptors 2 and 4.Interactions between dendritic cells and T lymphocytes in pathogenesis of nasal polyps.Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.

P2860

Q26781529-B3C7835C-A038-4A83-B891-146C22BEBB1B Q37256159-8DB28240-3F00-4ABE-96F3-B5F51318EF19 Q37533397-6D70135B-F65E-4B58-B2DB-FBE9DE8B1B6C Q38896543-F271E7B2-EC4E-472E-876F-6F52FF47D0BE Q42102122-C889425A-1CBB-47DB-80D0-110E79513A97 Q42694613-6BFB311C-4EB3-4111-B3C9-6D4931421AB8 Q49376559-0ECF9C4A-513D-4A03-9D29-5245D75428EA Q55248689-BDC933A2-B476-417E-9110-5807806C7EA7 Q55258910-CE55DBB1-1B89-4201-B3B5-87CA60A554DC

P2860

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

http://www.wikidata.org/entity/Q28082878

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

@ast

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

@en

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

@nl

type

label

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

@ast

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

@en

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

@nl

prefLabel

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

@ast

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

@en

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

@nl

P1433

Q28082878-816C4304-B173-4669-9638-B44104B89E00

P1476

Q28082878-21F015B1-293E-4728-8037-E4DBF0F881D9

P2093

Q28082878-045872B2-0DCF-47C7-BC42-E03276364DE6

Q28082878-1977CB41-210D-4217-8EDB-42C08EBC551A

Q28082878-3349F0DA-3FCF-483C-A0B3-04344C9B9BC3

Q28082878-C6D53F2E-4479-458F-AF62-77DEE998EAFE

Q28082878-D129CBA1-5047-4888-BFB0-FFBCEA7864D2

Q28082878-F9D28834-569F-499B-8D1F-4D82E5BCBDD7

P275

Q28082878-9FAE4FAF-84E9-49D9-B4EF-E4F9E406858F

P2860

Q28082878-024F28A5-DF5F-4361-A8B8-29993326F414

Q28082878-02C3B317-798F-4D53-B0F5-BE33862ECFA8

Q28082878-02F60D5D-BD98-4936-8F61-C67F075841E3

Q28082878-06F9E331-8256-427D-B2D0-11F70CD31F35

Q28082878-08148B63-8C18-4227-A8FE-6E302AA8D460

Q28082878-0A2A0417-08D7-4297-9E7A-F903C3495DE6

Q28082878-121D67F9-CDD8-44F4-9552-E439A79C5D91

Q28082878-136DE7E2-C645-4CFF-ABF3-C13987CAF92D

Q28082878-137262F5-F77C-472D-871C-582AAD706E09

Q28082878-16043DB7-23BB-48BE-BF82-74F60F75C4BD

P304

Q28082878-89DAF2AA-4C55-4B61-9C9E-75023BC34417

P31

Q28082878-6EDC8418-A93B-49B6-A874-6FAA81B17B64

Q28082878-A56E2D41-91E3-4FE9-921D-32CD72279E06

P3181

Q28082878-A573B3F2-D181-4916-A658-902E46718903

P356

Q28082878-C9E7DEEA-5045-43C9-ACBE-045AF643DC11

P407

Q28082878-F3FAD0C3-9F31-4D67-8218-F83F009B1464

P478

Q28082878-DBC9EDC4-6272-4E4B-BA56-DE9AC957DDE0

P5008

Q28082878-F65CF6FC-B461-4F8F-85EB-7C9E3F59F710

P577

Q28082878-4FE9EBFE-43CA-459B-813A-EFC12475EA24

Q28082878-F46B657C-5425-4B0F-964D-CB6A7535DB3A

P5875

Q28082878-8A134763-590B-45CB-A4DF-69F03894D7F0

P698

Q28082878-5CC8E2D4-09E6-4C63-B281-F0840719F646

P921

Q28082878-254D4231-EA93-4870-A2B2-16EB0FD2108B

Q28082878-539B4C1C-5F71-4774-BF29-7EB6701FDB73

Q28082878-6F60D836-399B-4DE5-9B4E-3325BEC5BDF0

Q28082878-C0B02572-09F5-47BA-883C-8DDA5974F9F1

P932

Q28082878-01CE0CE6-A8D6-4F7F-BE70-A63CDA017995

P3181

P356

P1433

Mediators of Inflammation

P1476

Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis

@en

P2093

Di-Hui Ma

http://www.w3.org/2001/XMLSchema#string

Hong-Liang Zhang

http://www.w3.org/2001/XMLSchema#string

Jie Zhu

http://www.w3.org/2001/XMLSchema#string

Tao Jin

http://www.w3.org/2001/XMLSchema#string

Xiu-Juan Wu

http://www.w3.org/2001/XMLSchema#string

Zhong-Xiang Xie

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

Interleukin-10: new perspectives on an old cytokine

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood

Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation

Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

Immune heterogeneity in neuroinflammation: dendritic cells in the brain

P304

513295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4835993

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2015/513295

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273952604

http://www.w3.org/2001/XMLSchema#string

P698

25705093

http://www.w3.org/2001/XMLSchema#string

P921

hemic and immune systems

multiple sclerosis

P932

4325219

http://www.w3.org/2001/XMLSchema#string